STRS Ohio’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,600
| Closed | -$244K | – | 1986 |
|
|
2024
Q2 | $244K | Buy |
6,600
+700
| +12% | +$25.9K | ﹤0.01% | 1507 |
|
|
2024
Q1 | $247K | Buy |
5,900
+3,200
| +119% | +$134K | ﹤0.01% | 1497 |
|
|
2023
Q4 | $107K | Buy |
2,700
+1,300
| +93% | +$51.5K | ﹤0.01% | 1686 |
|
|
2023
Q3 | $38K | Sell |
1,400
-5,100
| -78% | -$138K | ﹤0.01% | 1823 |
|
|
2023
Q2 | $220K | Buy |
6,500
+500
| +8% | +$16.9K | ﹤0.01% | 1571 |
|
|
2023
Q1 | $215K | Buy |
6,000
+4,800
| +400% | +$172K | ﹤0.01% | 1582 |
|
|
2022
Q4 | $53K | Buy |
+1,200
| New | +$53K | ﹤0.01% | 1801 |
|
|
2022
Q1 | – | Sell |
-6,300
| Closed | -$243K | – | 2154 |
|
|
2021
Q4 | $243K | Hold |
6,300
| – | – | ﹤0.01% | 1678 |
|
|
2021
Q3 | $340K | Buy |
+6,300
| New | +$340K | ﹤0.01% | 1627 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 1927 |
|
|
2015
Q3 | – | Sell |
-553
| Closed | -$209K | – | 1893 |
|
|
2015
Q2 | $209K | Sell |
553
-174
| -24% | -$65.8K | ﹤0.01% | 1551 |
|
|
2015
Q1 | $303K | Buy |
+727
| New | +$303K | ﹤0.01% | 1355 |
|
|
2014
Q2 | – | Sell |
-1,013
| Closed | -$269K | – | 1709 |
|
|
2014
Q1 | $269K | Hold |
1,013
| – | – | ﹤0.01% | 1355 |
|
|
2013
Q4 | $368K | Sell |
1,013
-114
| -10% | -$41.4K | ﹤0.01% | 1282 |
|
|
2013
Q3 | $599K | Buy |
1,127
+680
| +152% | +$361K | ﹤0.01% | 1148 |
|
|
2013
Q2 | $105K | Buy |
+447
| New | +$105K | ﹤0.01% | 1623 |
|